CEACAM5 and colorectal carcinoma: While there may be a correlation between ctDNA and CEA measurements, comparison of the sensitivity of ctDNA and CEA for CRC recurrence has consistently demonstrated superiority of ctDNA assays, regardless of biomarker applied (Table 3).